BIO vs LH · rev $651.0M vs P/E 23, rev $7.27B
BIO (BIO) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
BIO currently screens at market cap $0. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the BIO and LH stock pages for the full models.
Not investment advice.